Dietary Supplement: N-111
Dietary SupplementDietary supplement N-111
NCT Number: NCT05410002
The study will look at the end result of 2 types of diets effect on treatment outcome of cancer patients using N-111.
Looking for future studies?
Notify Me25 year–80 year
All sexes
Interventional
Phase 1
KLE Academy of Higher Education & Research, Belagāve, Karnataka, India
The study will be evaluated during a double blind, placebo-controlled evaluation of the effect diet has on the response of patients taking N-111 who are on a vegetarian diet vs a non-vegetarian diet or a placebo. This will involve assessing the patients progress or lack thereof over a 3-month period of time as outlined in Outcome Measures section below.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dietary supplement N-111
Dietary placebo
Time frame: End of month 3.
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Time frame: End of month 3.
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Time frame: End of month 3.
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Time frame: End of month 3.
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Optimal Health Research
Other
A Study on the Effect Diet Has Affecting the Response of Patients Taking N-111 Who Are on a Vegetarian Diet Vs a Non-vegetarian Diet or a Placebo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06551688
Avitaminosis, Breast Diseases
El Fayoum Qesm, Faiyum Governorate, Egypt
View Trial DetailsNCT07205965
Anxiety Disorders, Behavior
Izmir, Turkey (Türkiye)
View Trial DetailsNCT04074460
Breast Diseases, Breast Neoplasms
Melbourne, Australia
View Trial DetailsNCT03452774
Adenocarcinoma, Adnexal Diseases
Birmingham, Alabama, United States
View Trial Details